Archived articles

Experimental drugs

Hope for Alzheimer's
Published Fall 2021
Two Johns Hopkins researchers race to bring a drug to market that holds promise for millions afflicted with the devastating cognitive disorder / Johns Hopkins Magazine
Medical marijuana
A sea change in CBD drug policy?
Published Oct 2, 2018
The DEA announced a shift Friday that clears the way for the first prescription drug derived from the marijuana plant to make its way to market
Parkinson's disease
Study identifies potential Parkinson's treatment
Published July 3, 2018
In mouse study, experimental drug similar to FDA-approved diabetes treatments shown to prevent motor impairment, extend life expectancy
Experimental medicine
Expanding access to trial drugs
Published Aug 1, 2017
Carey Business School expert proposes guidelines to help terminally ill patients gain access to drugs in clinical trials
Pure Ecstasy?
Pill testing could reduce risks
Published July 10, 2017
Many at music festivals, raves say they wouldn't take Ecstasy pills shown to be adulterated or fake
Plantibodies v. Ebola
Published Winter 2014
The development of experimental Ebola drug ZMapp has its experimental roots in the lab of Johns Hopkins biophysicist Richard Cone. / Johns Hopkins Magazine